Vishwas Paralkar is a Member of the Scientific Advisory Board at Modifi Bio, where Vishwas currently works. Prior to this, Vishwas served as the Chief Scientific Officer at Cybrexa Therapeutics and Karos Pharmaceuticals, where Vishwas had a successful exit after the sale of the company. Vishwas also held various positions at Pfizer Pharmaceuticals and SVP Pfizer before that. Paralkar has a PhD in Cell Biology/Biochemistry from Howard University.
Current role
Chief Scientific Officer & Co-founder at Moonvalley
EVP, Research & Development & Chief Scientific Officer at AbbVie
Chief Scientific Officer at Medichem S.A.
Chief Scientific Officer at Rhythm AI
President Of Research & Development And Chief Scientific Officer at Karuna Therapeutics
Access the worlds's biggest network of public org charts
Learn more